ProfileGDS4132 / 209636_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 37% 41% 30% 28% 32% 34% 34% 33% 32% 31% 34% 35% 38% 35% 22% 26% 32% 32% 31% 33% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10193.88737
GSM201543Muscle PCOS pioglitazone 12196.849241
GSM201544Muscle PCOS pioglitazone 16176.218830
GSM201545Muscle PCOS pioglitazone 20173.880228
GSM201829Muscle PCOS pioglitazone 23183.644832
GSM201830Muscle PCOS pioglitazon 25189.085934
GSM201831Muscle PCOS pioglitazone 27182.706834
GSM201832Muscle PCOS pioglitazone 3182.65633
GSM201833Muscle PCOS pioglitazone 4174.467532
GSM201834Muscle PCOS pioglitazone 8174.657431
GSM201835Muscle PCOS after pioglitazone 10270.988634
GSM201836Muscle PCOS after pioglitazone 12278.932235
GSM201837Muscle PCOS after pioglitazone 16280.878338
GSM201838Muscle PCOS after pioglitazone 20277.72935
GSM201839Muscle PCOS after pioglitazone 23245.991622
GSM201840Muscle PCOS after pioglitazone 25259.831626
GSM201841Muscle PCOS after pioglitazone 27264.886732
GSM201842Muscle PCOS after pioglitazone 3262.914732
GSM201843Muscle PCOS after pioglitazone 4274.249231
GSM201844Muscle PCOS after pioglitazone 8277.108133